These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 34010070)

  • 1. Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19.
    Sahai A; Bhandari R; Godwin M; McIntyre T; Chung MK; Iskandar JP; Kamran H; Hariri E; Aggarwal A; Burton R; Kalra A; Bartholomew JR; McCrae KR; Elbadawi A; Bena J; Svensson LG; Kapadia S; Cameron SJ
    Vasc Med; 2021 Dec; 26(6):626-632. PubMed ID: 34010070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 Patients.
    Sahai A; Bhandari R; Koupenova M; Freedman JE; Godwin M; McIntyre T; Chung MK; Iskandar JP; Kamran H; Hariri E; Aggarwal A; Kalra A; Bartholomew JR; McCrae KR; Elbadawi A; Svensson LG; Kapadia S; Cameron SJ
    Res Sq; 2020 Dec; ():. PubMed ID: 33398263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.
    Zhang S; Liu Y; Wang X; Yang L; Li H; Wang Y; Liu M; Zhao X; Xie Y; Yang Y; Zhang S; Fan Z; Dong J; Yuan Z; Ding Z; Zhang Y; Hu L
    J Hematol Oncol; 2020 Sep; 13(1):120. PubMed ID: 32887634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial.
    Connors JM; Brooks MM; Sciurba FC; Krishnan JA; Bledsoe JR; Kindzelski A; Baucom AL; Kirwan BA; Eng H; Martin D; Zaharris E; Everett B; Castro L; Shapiro NL; Lin JY; Hou PC; Pepine CJ; Handberg E; Haight DO; Wilson JW; Majercik S; Fu Z; Zhong Y; Venugopal V; Beach S; Wisniewski S; Ridker PM;
    JAMA; 2021 Nov; 326(17):1703-1712. PubMed ID: 34633405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With Influenza.
    Lund LC; Reilev M; Hallas J; Kristensen KB; Thomsen RW; Christiansen CF; Sørensen HT; Johansen NB; Brun NC; Voldstedlund M; Støvring H; Thomsen MK; Christensen S; Pottegård A
    JAMA Netw Open; 2020 Jul; 3(7):e2013880. PubMed ID: 32609352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Colchicine and Low-Dose Aspirin Combination Therapy for Non-elderly, Non-severe, Early Time From Onset, Adult Outpatients with Coronavirus Disease 2019 (COVID-19) during "The Fifth Pandemic Wave" in Japan.
    Inokuchi T; Homma T; Kitasato Y; Akiyama M; Chikasue A; Nishii Y; Ban S; Adachi T; Sonezaki A; Masuda H; Kamei H; Takenaka M; Tanaka M; Okamoto M; Hoshino T;
    Kurume Med J; 2024 Jul; 70(1.2):39-45. PubMed ID: 38508737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19.
    D'Souza R; Malhamé I; Teshler L; Acharya G; Hunt BJ; McLintock C
    Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1110-1120. PubMed ID: 32678949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
    Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
    PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Aspirin on the Prevention of Pro-thrombotic States in Hospitalized COVID-19 Patients: Systematic Review.
    Abdi M; Lamardi ZH; Shirjan F; Mohammadi L; Abadi SSD; Massoudi N; Zangiabadian M; Nasiri MJ
    Cardiovasc Hematol Agents Med Chem; 2022; 20(3):189-196. PubMed ID: 35366783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis.
    White WB; Strand V; Roberts R; Whelton A
    Am J Ther; 2004; 11(4):244-50. PubMed ID: 15266215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose aspirin and clinical outcomes in patients with SARS-CoV-2 pneumonia: a propensity score-matched cohort analysis from the National SIMI‑COVID‑19 Registry.
    Dalbeni A; Susca N; Daidone M; Rossi I; Giontella A; Cimellaro A; Talerico G; Pietrangelo A; Sesti G; Zaccone V; Villani R;
    Intern Emerg Med; 2023 Nov; 18(8):2311-2319. PubMed ID: 37751084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationales and uncertainties for aspirin use in COVID-19: a narrative review.
    Sayed Ahmed HA; Merrell E; Ismail M; Joudeh AI; Riley JB; Shawkat A; Habeb H; Darling E; Goweda RA; Shehata MH; Amin H; Nieman GF; Aiash H
    Fam Med Community Health; 2021 Apr; 9(2):. PubMed ID: 33879541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and bleeding in dentistry: an update and recommendations.
    Brennan MT; Wynn RL; Miller CS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Sep; 104(3):316-23. PubMed ID: 17618144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.
    Manolis AS; Manolis TA; Manolis AA; Papatheou D; Melita H
    J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):12-24. PubMed ID: 32924567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
    Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
    Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19.
    Haji Aghajani M; Moradi O; Amini H; Azhdari Tehrani H; Pourheidar E; Rabiei MM; Sistanizad M
    J Med Virol; 2021 Sep; 93(9):5390-5395. PubMed ID: 33913549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia.
    Sullerot C; Bouiller K; Laborde C; Gilis M; Fèvre A; Hacquin A; Manckoundia P; Hoefler F; Bermejo M; Mendes A; Serratrice C; Prendki V; Sanchez S; Putot A;
    Geroscience; 2022 Apr; 44(2):573-583. PubMed ID: 34993763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy.
    Nagata N; Niikura R; Aoki T; Shimbo T; Kishida Y; Sekine K; Tanaka S; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
    J Gastroenterol Hepatol; 2014 Oct; 29(10):1786-93. PubMed ID: 24720424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic complications of COVID-19.
    Avila J; Long B; Holladay D; Gottlieb M
    Am J Emerg Med; 2021 Jan; 39():213-218. PubMed ID: 33036855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets.
    Violi F; Cammisotto V; Pignatelli P
    Platelets; 2021 Nov; 32(8):1009-1017. PubMed ID: 34097572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.